8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)
Published . Updated .
Key takeaways
- 8-K - PRECISION BIOSCIENCES filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
- Exposed: DTIL
- Market reaction: DTIL +52.3% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - PRECISION BIOSCIENCES filed an 8-K with the SEC on Nov 3 (a notice of a material company event).
Directly affected
- DTIL Precision Biosciences
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Precision BioSciences belongs to, so it often moves with news about it.
- AMGN Amgen
Amgen is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences
Gilead Sciences is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna
Moderna is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE
argenx SE is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Precision BioSciences in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| DTIL | -2.16% | +6.61% | base | -0.29% | +15.95% | +41.52% | +52.30% |
| XLV | -2.95% | -0.31% | base | -0.34% | +2.73% | +0.31% | +0.13% |
| AMGN | -3.75% | -1.04% | base | -0.92% | +2.72% | -1.06% | -0.89% |
| GILD | -6.65% | -2.82% | base | -1.70% | +2.38% | -1.69% | -1.64% |
| MRNA | -5.90% | +0.84% | base | +3.40% | +16.98% | +9.28% | +19.24% |
| ARGX | +0.87% | +2.64% | base | +3.02% | +6.49% | +2.22% | +5.44% |
| RVMD | -1.02% | +1.20% | base | +3.19% | +6.03% | -5.48% | +3.37% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-03 AccNo: 0001628280-26-069115 Size: 249 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Precision Biosciences (DTIL) has moved since 3 Nov 2026
Since the first closing price after “8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer),” Precision Biosciences (DTIL) is +18.03%.
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | that day | -0.92% | final price |
| AMGN | the next day | +2.72% | final price |
| AMGN | two days later | -1.06% | final price |
| AMGN | three days later | -0.89% | final price |
| AMGN | three days earlier | -1.04% | final price |
| AMGN | five days earlier | -3.75% | final price |
| ARGX | that day | +3.02% | final price |
| ARGX | the next day | +6.49% | final price |
| ARGX | two days later | +2.22% | final price |
| ARGX | three days later | +5.44% | final price |
| ARGX | three days earlier | +2.64% | final price |
| ARGX | five days earlier | +0.87% | final price |
| Precision Biosciences (DTIL) | that day | -0.29% | final price |
| Precision Biosciences (DTIL) | the next day | +15.95% | final price |
| Precision Biosciences (DTIL) | two days later | +41.52% | final price |
| Precision Biosciences (DTIL) | three days later | +52.30% | final price |
| Precision Biosciences (DTIL) | three days earlier | +6.61% | final price |
| Precision Biosciences (DTIL) | five days earlier | -2.16% | final price |
| GILD | that day | -1.70% | final price |
| GILD | the next day | +2.38% | final price |
| GILD | two days later | -1.69% | final price |
| GILD | three days later | -1.64% | final price |
| GILD | three days earlier | -2.82% | final price |
| GILD | five days earlier | -6.65% | final price |
| MRNA | that day | +3.40% | final price |
| MRNA | the next day | +16.98% | final price |
| MRNA | two days later | +9.28% | final price |
| MRNA | three days later | +19.24% | final price |
| MRNA | three days earlier | +0.84% | final price |
| MRNA | five days earlier | -5.90% | final price |
| RVMD | that day | +3.19% | final price |
| RVMD | the next day | +6.03% | final price |
| RVMD | two days later | -5.48% | final price |
| RVMD | three days later | +3.37% | final price |
| RVMD | three days earlier | +1.20% | final price |
| RVMD | five days earlier | -1.02% | final price |
| XLV | that day | -0.34% | final price |
| XLV | the next day | +2.73% | final price |
| XLV | two days later | +0.31% | final price |
| XLV | three days later | +0.13% | final price |
| XLV | three days earlier | -0.31% | final price |
| XLV | five days earlier | -2.95% | final price |
Trades by members of Congress and officials in the stocks in this story
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 19 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 42 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 69 days before publication. Filed 5 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 85 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 67 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)”
Companies mentioned with this story
- DTIL Precision Biosciences
In “8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer),” Precision Biosciences (DTIL) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> DTIL
How “8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)” reaches Precision Biosciences (DTIL)
The 3 Nov 2026 story “8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)” names Precision Biosciences (DTIL) because of this story.
The link for Precision Biosciences (DTIL) is this: SEC 8-K filing -> direct issuer disclosure -> DTIL
Price levels for Precision Biosciences (DTIL)
DTIL traded between 5.97 and 11.24 across 13 sessions. The latest close on file is 9.53.
How strong the case is around Precision Biosciences (DTIL)
14 out of 100
“8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.